SciSparc Ltd. Ordinary Shares (SPRC)
SciSparc Ltd. is a clinical-stage biopharmaceutical company focused on developing and commercializing treatments for central nervous system (CNS) disorders. The company specializes in leveraging proprietary formulations of cannabinoids and other compounds to address conditions such as schizophrenia, autism spectrum disorder, and other neurological and psychiatric conditions. SciSparc aims to advance innovative therapies through research and clinical trials to improve patient outcomes in CNS health.
Company News
SciSparc's stock surged 89.13% after hours following a court-granted stay in its merger proceedings with AutoMax Motors until September 30, amid ongoing challenges in completing the merger agreement.
Over 50 companies are advancing cannabinoid drug research, exploring potential treatments for mental health disorders, neurodegenerative diseases, and chronic inflammation, with promising clinical trials targeting conditions like Alzheimer's, pain management, and epilepsy.
Use these tips to handle short term penny stocks price movements The post Dealing With Penny Stocks’ Short Term Price Movements appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.